|
|
|
|
Endocrine and metabolic effects of glucagon like peptide 1 receptor agonists (GLP1RA)
|
|
|
|
|
|
|
|
نویسنده
|
kalra s. ,gupta y.
|
|
منبع
|
journal of the pakistan medical association - 2016 - دوره : 66 - شماره : 3 - صفحه:357 -359
|
|
چکیده
|
This brief review describes the potential non-glycaemic effects and benefits of glucagon like peptide 1 receptor agonists (glp1ra). it lists various indications in which this class of drugs has been used,and explains the rationale behind this use. the potential uses of glp1ra extend across the entire spectrum of endocrinology and metabolism,from hypothalamic obesity to non-alcoholic steatohepatitis (nash) to polycystic ovary syndrome (pcos). the article also discusses and addresses endocrine-related concerns related to the glp1ras. © 2016,university of economics - prague. all reserved.
|
|
کلیدواژه
|
Exenatide; Exenatide QW; Incretin therapy; Liraglutide
|
|
آدرس
|
department of endocrinology,bharti hospital,karnal, Pakistan, department of endocrinology,all india institute of medical sciences,new delhi, India
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|